![Nagesh Kumar Middey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nagesh Kumar Middey
Algemeen Directeur bij Celon Laboratories Ltd.
Profiel
Nagesh Kumar Middey is currently the Chief Executive Officer & Director at Celon Laboratories Ltd.
since 2018 and the Director at Mviyes Pharma Ventures Pvt Ltd.
since 2017.
He graduated from Osmania University.
Actieve functies van Nagesh Kumar Middey
Bedrijven | Functie | Begin |
---|---|---|
Mviyes Pharma Ventures Pvt Ltd.
![]() Mviyes Pharma Ventures Pvt Ltd. MiscellaneousMiscellaneous Mviyes Pharma Ventures Pvt Ltd. operates as a holding company. The company was founded on March 30, 2017 and is headquartered in Hyderabad, India. | Directeur/Bestuurslid | 30-03-2017 |
Celon Laboratories Ltd.
![]() Celon Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Celon Laboratories Ltd. develops and markets pharmaceuticals products. Its products include oncology and critical care which encompass Alakcel, Capcel, Celcarb, Celdaz, Celplat, Celtax, Celofos, and Temolon, critical care include Arium, Buloc, Hypro and Hypro Melt, Vibro, and Stimin and Stimin G. The company was founded by K. V. Ravindra in 2007 and is headquartered in Hyderabad, India. | Algemeen Directeur | 01-10-2018 |
Opleiding van Nagesh Kumar Middey
Osmania University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Mviyes Pharma Ventures Pvt Ltd.
![]() Mviyes Pharma Ventures Pvt Ltd. MiscellaneousMiscellaneous Mviyes Pharma Ventures Pvt Ltd. operates as a holding company. The company was founded on March 30, 2017 and is headquartered in Hyderabad, India. | Miscellaneous |
Celon Laboratories Ltd.
![]() Celon Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Celon Laboratories Ltd. develops and markets pharmaceuticals products. Its products include oncology and critical care which encompass Alakcel, Capcel, Celcarb, Celdaz, Celplat, Celtax, Celofos, and Temolon, critical care include Arium, Buloc, Hypro and Hypro Melt, Vibro, and Stimin and Stimin G. The company was founded by K. V. Ravindra in 2007 and is headquartered in Hyderabad, India. | Health Technology |